Interaction Between Endothelial Nitric Oxide Synthase Gene Polymorphisms (鈭?86T>C, 894G>T and Intron 4 a/b) and Cardiovascular Risk Factors in Acute Coronary Syndromes

详细信息	查看全文 | 推荐本文 |

• 作者：Jacqueline da Costa Escobar Piccoli^a ; ^b ; ^{jcepiccoli@yahoo.com.br} ; Vanusa Manfredini^a ; Fernanda Irma Hamester^b ; Josiane Bettim Bandinelli^b ; Ilan Maltz Turkienicz^b ; José ; Artur Bogo Chies^c ; Alessandra Peres^d ; Luiz Carlos Bodanese^e ; Maurí ; cio Reis Bogo^b
• 关键词：eNOS ; Endothelial nitric oxide polymorphisms ; Nitric oxide ; Cardiovascular risk factors ; Acute coronary syndrome
• 刊名：Archives of Medical Research
• 出版年：2012
• 期刊代码：24_01884409
• 类别：med
• 出版时间：April, 2012
• 卷：43
• 期：3
• 页码：205-211
• 文件大小：125 K

摘要

| Figures/TablesFigures/Tables | ReferencesReferences

Background and Aims

Endothelial rupture of coronary plaque can represent the pathomorphological substratum of acute coronary syndrome (ACS). Polymorphisms in the NOS3 gene (eNOS) -786T>C, 894G>T and intron 4 a/b VNTR can be associated with a higher susceptibility for ACS. The present study is focused on the investigation of the interaction of these polymorphisms and cardiovascular risk factors in 135 patients with ACS and 115 control subjects.

Methods

Case-control study where the allele and genotype frequencies of the polymorphisms -786T> C, 894G> T and intron 4 VNTR of the gene encoding eNOS were determined by PCR-RFLP associated with cardiovascular risk factors.

Results

An association of the 894TT genotype and 894GT+GG (OR 1.4; 95%CI聽1.0-1.8) in ACS has been observed. Subjects without dyslipidemia and intron 4 a/b genotype present a lower chance for ACS development, whereas subjects without diabetes and 894TT genotype show a higher risk for ACS (OR 1.7; 95%CI 1.2-2.3). In patients without dyslipidemia, the 894GG genotype presented a tendency to behave as a protector factor against ACS. Also, the 894GG genotype has been a protective factor for ACS in females (OR 0.5; CI 95%0.2-0.9).

Conclusions

Our results suggest that eNOS polymorphisms may be an additional risk factor in development of ACS.